Earlier publication of Q1 report

Allenex AB (publ) is adjusting the Q1 report release date to the financial
calendar of CareDx Inc. and will therefore publish the Q1 2016 report on May 6th
at 12.30 CET. The previously communicated date for this report was May 19th
2016.

For more information please contact:
Anders Karlsson, CEO Allenex AB, and ph.: +4670-918 00 10, e-mail:
anders.karlsson@allenex.se

Allenex AB discloses the information provided herein pursuant to the Securities
Markets Act and /or the Financial Instruments Trading Act. The information was
submitted for publication on April 27, 2016, at 13.00 CET.  Allenex is a life
science-company that develops, manufacture, market and sell products for safer
transplants of organs and bone marrow on the global market. Allenex is listed on
NASDAQ OMX Stockholm Small Cap (ticker: ALNX). 57 persons are employed in the
Allenex group.